Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer

Cancer Biology and Therapy

Volumn 6, Issue 5, 2007, Pages 712-718

  Zhi, Jiang Zang ^a,b   Khe, Guan Sim ^a   Jit, Kong Cheong ^a,b   Yang, Christopher Maolin ^a   Chui, Sun Yap ^a   Hsu, Stephen I Hong ^a,b,c  

^a Dept Medicine Endocrinol Diabet   (Singapore)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bromodomain; Cell cycle progression; Chick embryo chorioallantoic membrane; Decoy peptide; Gene transcription; Molecular therapy; Neoplasm; PHD zinc finger; TRIP Br; Tumor xenograft model

Indexed keywords

ANTINEOPLASTIC AGENT; BROXURIDINE; CASPASE 3; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN TRIP BR; PROTEIN TRIP BR1; PROTEIN TRIP BR2; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER RESEARCH; CELL CYCLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NASOPHARYNX CANCER; NONHUMAN; ONCOGENE; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT; UTERINE CERVIX CANCER; WESTERN BLOTTING;

EID: 34548254854     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.5.3964     Document Type: Article

References (23)

1. Hsu SI, Yang CM, Sim KG, Hentschel DM, O'Leary E, Bonventre JV. TRIP-Br: A novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1. EMBO J 2001; 20:2273-85.
2. Sugimoto M, Nakamura T, Ohtani N, Ohtani N, Hampson L, Hampson IN, Shimamoto A, Furuichi Y, Okumura K, Niwa S, Taya Y, Hara E. Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1). Genes Dev 1999; 13:3027-33.
3. Watanabe-Fukunaga R, Iida S, Shimizu Y, Nagata S, Fukunaga R. SEI family of nuclear factors regulates p53-dependent transcriptional activation. Genes Cells 2005; 10:851-60.
4. Sim KG, Cheong JK, Hsu SI. The TRIP-Br family of transcriptional regulators is essential for the execution of cyclin E-mediated cell cycle progression. Cell Cycle 2006; 5:1111-5.
5. Gladden AB, Diehl JA. Location, location, location: The role of cyclin D1 nuclear localization in cancer. J Cell Biochem 2005; 96:906-13.
6. Tang TC, Sham JS, Xie D, Fang Y, Huo KK, Wu QL, Guan XY. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines. Cancer Res 2002; 62:7157-61.
7. Zhu L. Tumour suppressor retinoblastoma protein Rb: A transcriptional regulator. Eur J Cancer 2005; 41:2415-27.
8. Tang DJ, Hu L, Xie D, Wu QL, Fang Y, Zeng Y, Sham JS, Guan XY. Oncogenic transformation by SEI-1 is associated with chromosomal instability. Cancer Res 2005; 65:6504-8.
9. Li J, Muscarella P, Joo SH, Knobloch TJ, Melvin WS, Weghorst CM, Tsai MD. Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A). Biochemistry 2005; 44:13246-56.
10. Sim KG, Zang Z, Yang CM, Bonventre JV, Hsu SI. TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability. Cell Cycle 2004; 3:1296-304.
11. Dani SU, Espindola R. A model system for testing gene vectors using murine tumor cells on the chorioallantoic membrane of the chick embryo. Genet Mol Res 2002; 1:167-75.
12. Calgaro S, Boube M, Cribbs DL, Bourbon HM. The Drosophila gene taranis encodes a novel trithorax group member potentially linked to the cell cycle regulatory apparatus. Genetics 2002; 160:547-60.
13. Abdullah JM, Jing X, Spassov DS, Nachtman RG, Jurecic R. Cloning and characterization of Hepp, a novel gene expressed preferentially in hematopoietic progenitors and mature blood cells. Blood Cells Mol Dis 2001; 27:667-76.
14. Hayashi R, Goto Y, Ikeda R, Yokoyama KK, Yoshida K. CDCA4 is an E2F transcription factor family-induced nuclear factor that regulates E2F-dependent transcriptional activation and cell proliferation. J Biol Chem 2006; 281:35633-48.
15. Cho JM, Song DJ, Bergeron J, Benlimame N, Wold MS, Alaoui-Jamali MA. RBT1, a novel transcriptional coactivator, binds the second subunit of replication protein A. Nucleic Acids Res 2000; 28:3478-85.
16. Adams PD, Kaelin Jr WG. Transcriptional control by E2F. Semin Cancer Biol 1995; 6:99-108.
17. Gupta S, Takhar PP, Degenkolbe R, Koh CH, Zimmermann H, Yang CM, Sim KG, Hsu SI, Bernard HU. The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1. Virology 2003; 317:155-64.
18. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002; 3:11-20.
19. Bienz M. The PHD finger, a nuclear protein-interaction domain. Trends Biochem Sci 2006; 31:35-40.
20. Zeng L, Zhou MM. Bromodomain: An acetyl-lysine binding domain. FEBS Lett 2002; 513:124-8.
21. Kisker O, Onizuka S, Banyard J, Komiyama T, Becker CM, Achilles EG, Barnes CM, O'Reilly MS, Folkman J, Pirie-Shepherd SR. Generation of multiple angiogenesis inhibitors by human pancreatic cancer. Cancer Res 2001; 61:7298-304.
22. Ribatti D, Vacca A, Roncali L, Dammacco F. The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. Curr Pharm Biotechnol 2000; 1:73-82.
23. Yokoyama Y, Iwata R, Hongo J, Murakami S, Wada A. A papillary out-growth pattern of early cervical cancer. Acta Obstet Gynaecol Jpn 1969; 16:258-62.